Skip to main content
TipRanks
Go Ultimate75% OFF

Taysha Gene Therapies (TSHA) Drug Pipeline

1,291 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Tsha-102Rett SyndromePhase IIIRecruitingSafety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett SyndromeMar 13, 2026―
Tsha-102Rett Syndromephase1AndPhase2Active Not RecruitingSafety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)Nov 21, 2023―
Tsha-102Rett SyndromePhase IIIRecruitingA Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)Oct 28, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Taysha Gene Therapies, Inc. (TSHA) have in its pipeline
Taysha Gene Therapies TSHA is currently developing the following drugs: Tsha-102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.